Table 3 Validation Cohort Demographics (n = 501)
Characteristic | Healthy N = 106 | CLD N = 147 | Fibrosis N = 129 | Cirrhosis N = 119 |
|---|---|---|---|---|
Age | Â | Â | Â | Â |
 Median (IQR) | 36 (30, 42) | 43 (35, 51) | 55 (42, 67) | 58 (52, 66) |
 Range | 21, 71 | 23, 78 | 19, 88 | 32, 86 |
Sex, n (%) | Â | Â | Â | Â |
 Male | 30 (28%) | 80 (54%) | 69 (53%) | 30 (25%) |
 Female | 76 (72%) | 67 (46%) | 60 (47%) | 89 (75%) |
Race, n (%) | Â | Â | Â | Â |
 Asian | 106 (100%) | 147 (100%) | 129 (100%) | 119 (100%) |
Etiology, n (%) | — |  |  |  |
 Viral |  | |||
  HBV |  | 89 (61%) | 30 (23%) | 17 (14%) |
  HCV |  | 0 (0%) | 2 (1.6%) | 3 (2.5%) |
  Fatty Liver Disease & HBV |  | 6 (4.1%) | 0 (0%) | 0 (0%) |
 Non-Viral |  | |||
  Alcoholic Liver Disease |  | 0 (0%) | 4 (3.1%) | 0 (0%) |
  Autoimmune Hepatitis |  | 6 (4.1%) | 2 (1.6%) | 0 (0%) |
  Fatty Liver Disease |  | 45 (31%) | 4 (3.1%) | 2 (1.7%) |
  Fatty Liver Disease & Autoimmune Hepatitis |  | 1 (0.7%) | 0 (0%) | 0 (0%) |
  Primary Biliary Cirrhosis |  | 0 (0%) | 0 (0%) | 81 (68%) |
  Non-Viral Cirrhosis |  | 0 (0%) | 0 (0%) | 9 (7.6%) |
  Non-Viral Fibrosis |  | 0 (0%) | 44 (34%) | 0 (0%) |
 Unknown |  | 0 (0%) | 43 (33%) | 7 (5.9%) |